Folgen
Michael S. Diamond
Michael S. Diamond
Bestätigte E-Mail-Adresse bei wusm.wustl.edu
Titel
Zitiert von
Zitiert von
Jahr
Batf3 deficiency reveals a critical role for CD8α+ dendritic cells in cytotoxic T cell immunity
K Hildner, BT Edelson, WE Purtha, M Diamond, H Matsushita, ...
Science 322 (5904), 1097-1100, 2008
21682008
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
D Pinto, YJ Park, M Beltramello, AC Walls, MA Tortorici, S Bianchi, ...
Nature 583 (7815), 290-295, 2020
17952020
Essential role of mda-5 in type I IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus
L Gitlin, W Barchet, S Gilfillan, M Cella, B Beutler, RA Flavell, ...
Proceedings of the National Academy of Sciences 103 (22), 8459-8464, 2006
14172006
Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation
V Lampropoulou, A Sergushichev, M Bambouskova, S Nair, EE Vincent, ...
Cell metabolism 24 (1), 158-166, 2016
11932016
ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).
MS Diamond, DE Staunton, AR de Fougerolles, SA Stacker, ...
The Journal of cell biology 111 (6), 3129-3139, 1990
11601990
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
E Cameroni, JE Bowen, LE Rosen, C Saliba, SK Zepeda, K Culap, ...
Nature 602 (7898), 664-670, 2022
11382022
Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation
MS Diamond, DE Staunton, SD Marlin, TA Springer
Cell 65 (6), 961-971, 1991
10821991
Potently neutralizing and protective human antibodies against SARS-CoV-2
SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ...
Nature 584 (7821), 443-449, 2020
10792020
IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia
Y Wang, KJ Szretter, W Vermi, S Gilfillan, C Rossini, M Cella, AD Barrow, ...
Nature immunology 13 (8), 753-760, 2012
10332012
A mouse model of Zika virus pathogenesis
HM Lazear, J Govero, AM Smith, DJ Platt, E Fernandez, JJ Miner, ...
Cell host & microbe 19 (5), 720-730, 2016
9992016
Shared and distinct functions of type I and type III interferons
HM Lazear, JW Schoggins, MS Diamond
Immunity 50 (4), 907-923, 2019
9902019
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
R Zang, MFG Castro, BT McCune, Q Zeng, PW Rothlauf, NM Sonnek, ...
Science immunology 5 (47), eabc3582, 2020
9832020
2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members
S Daffis, KJ Szretter, J Schriewer, J Li, S Youn, J Errett, TY Lin, ...
Nature 468 (7322), 452-456, 2010
9492010
Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity
JW Schoggins, DA MacDuff, N Imanaka, MD Gainey, B Shrestha, ...
Nature 505 (7485), 691-695, 2014
9392014
Modified mRNA vaccines protect against Zika virus infection
JM Richner, S Himansu, KA Dowd, SL Butler, V Salazar, JM Fox, ...
Cell 168 (6), 1114-1125. e10, 2017
9182017
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ...
Nature medicine 27 (4), 717-726, 2021
9072021
Herpesvirus latency confers symbiotic protection from bacterial infection
ES Barton, DW White, JS Cathelyn, KA Brett-McClellan, M Engle, ...
Nature 447 (7142), 326-329, 2007
8962007
Zika virus infection during pregnancy in mice causes placental damage and fetal demise
JJ Miner, B Cao, J Govero, AM Smith, E Fernandez, OH Cabrera, ...
Cell 165 (5), 1081-1091, 2016
8952016
The broad-spectrum antiviral functions of IFIT and IFITM proteins
MS Diamond, M Farzan
Nature Reviews Immunology 13 (1), 46-57, 2013
8832013
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
ES Winkler, AL Bailey, NM Kafai, S Nair, BT McCune, J Yu, JM Fox, ...
Nature immunology 21 (11), 1327-1335, 2020
8592020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20